Education
About Us
Working with TipRanks
Follow Us
iX Biopharma Ltd. (SG:42C)
:42C
RESEARCH TOOLSreports
42C Stock Chart & Stats
Day’s Range― - ―
52-Week RangeS$0.02 - S$0.03
Previous CloseN/A
Volume104.10K
Average Volume (3M)274.58K
Market Cap
S$16.87M
Enterprise ValueS$24.66M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.47
Next Earnings
Feb 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding887,959,500
10 Day Avg. Volume72,280
30 Day Avg. Volume274,576
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
iX Biopharma Ltd. News
42C FAQ
What was iX Biopharma Ltd.’s price range in the past 12 months?
iX Biopharma Ltd. lowest share price was S$0.01 and its highest was S$0.03 in the past 12 months.
What is iX Biopharma Ltd.’s market cap?
iX Biopharma Ltd.’s market cap is S$16.87M.
When is iX Biopharma Ltd.’s upcoming earnings report date?
iX Biopharma Ltd.’s upcoming earnings report date is Feb 06, 2026 which is in 167 days.
How were iX Biopharma Ltd.’s earnings last quarter?
Currently, no data Available
Is iX Biopharma Ltd. overvalued?
According to Wall Street analysts iX Biopharma Ltd.’s price is currently Overvalued.
Does iX Biopharma Ltd. pay dividends?
iX Biopharma Ltd. does not currently pay dividends.
What is iX Biopharma Ltd.’s EPS estimate?
iX Biopharma Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does iX Biopharma Ltd. have?
iX Biopharma Ltd. has 887,959,500 shares outstanding.
What happened to iX Biopharma Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of iX Biopharma Ltd.?
Currently, no hedge funds are holding shares in SG:42C
Company Description
iX Biopharma Ltd.
iX Biopharma Ltd is a Singapore-based specialty pharmaceutical and nutraceutical company focused on the development, manufacture, and commercialization of therapies for the treatment of acute and breakthrough pain, and other health conditions. Its products under development are Wafermine and BnoX for pain management, Wafesil for erectile dysfunction, WafeRest for improved sleep quality, and others. Its business segments are Specialty Pharmaceutical and Nutraceutical business segments. The firm's business segments operate in Singapore, Australia, and China, of which the majority of the revenue comes from China..
Technical Analysis
Hyphens Pharma International Ltd.
―
Pharmesis International Ltd.
―
Singapore Paincare Holdings Limited
―
Alliance Healthcare Group Ltd.
―
Beverly JCG Ltd.
―
Ownership Overview
1.60% Insiders
―
Mutual Funds
― Other Institutional Investors
98.40% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---